logo

For the Inventor, By the Inventor

Culver City, CA, United States of America

Immunitybio, Inc.


USPTO Granted Patents = 63



Trademarks = 14

Forward Citations = 77

Loading Chart...
Loading Chart...

56 inventors (with patents filed for the assignee):

goldMedal Patrick Soon-Shiong (25 out of 476 patents)

silverMedal Hans G Klingemann (22 out of 47 patents)

bronzeMedal Laurent H Boissel (18 out of 36 patents)

4.  Hing C Wong (11 out of 111 patents)

5.  Barry J Simon (8 out of 18 patents)

6.  Nicholas James Witchey (8 out of 160 patents)

7.  Kayvan R Niazi (7 out of 101 patents)

8.  John Zachary Sanborn (6 out of 63 patents)

9.  Luna Witchey (6 out of 6 patents)

10.  Shahrooz Rabizadeh (5 out of 86 patents)

11.  Rohit Duggal (5 out of 5 patents)

12.  Ranjeet Sinha (4 out of 4 patents)

13.  Abhijit Dandapat (4 out of 5 patents)

14.  Himani Chinnapen (4 out of 4 patents)

15.  John H Lee (3 out of 13 patents)


Core Competencies:
Chimeric Antigen Receptor
NK Cells
Immunotherapy
Vaccines
Neuroinflammation
T-cell Memory
Bioprocessing
Tumor Microenvironment
SARS-CoV-2
Adenoviral Vectors
Mononuclear Cells
Protein Production

63 patents:

1. 12754189 - DRUG-SPECIFIC PHARMACOKINETIC ASSAY FOR IL-15 SUPERAGONIST (2026-10-06),
2. 12681020 - Compositions and Methods for NK-92 Cells Expressing Native CD16 (2026-07-14),
3. 12653874 - Nant cancer vaccine (2026-06-16),
4. 12594323 - METHODS OF REDUCING NEUROINFLAMMATION (2026-04-07),
5. 12558408 - Intratumorally injected yeast vaccine (2026-02-24),
6. 12516112 - SINGLE-CHAIN CHIMERIC POLYPEPTIDES AND USES THEREOF (2026-01-06),
7. 12509494 - MULTI-CHAIN CHIMERIC POLYPEPTIDES AND USES THEREOF (2025-12-30),
8. 12503680 - Methods and systems for cell bed formation during bioprocessing (2025-12-23),
9. 12497462 - ANTI-CD26 PROTEINS AND USES THEREOF (2025-12-16),
10. 12492377 - MODIFIED NK-92 haNK003 CELLS FOR THE CLINIC (2025-12-09),
11. 12491201 - Maximizing T-cell memory and compositions and methods therefor (2025-12-09),
12. 12479899 - MULTI-CHAIN CHIMERIC POLYPEPTIDES AND USES THEREOF (2025-11-25),
13. 12459981 - Primary NK CAR constructs and methods (2025-11-04),
14. 12456240 - Fiducial localization with sparse annotations (2025-10-28),
15. 12448638 - Enzyme based system for production of messenger RNA with increased transfection efficiency (2025-10-21),
Company Overview
ImmunityBio, Inc., based in Culver City, CA, specializes in innovative immunotherapy solutions, focusing on the development of Chimeric Antigen Receptor (CAR) technologies. The company is dedicated to harnessing the power of natural killer (NK) cells and T-cell memory to create advanced vaccines and therapies targeting various cancers and neuroinflammatory conditions. By exploring the tumor microenvironment and optimizing bioprocessing techniques, ImmunityBio aims to enhance patient outcomes through cutting-edge treatments in the field of immunology.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

Immunitybio, Inc. USPTO Patent Assignee Logo
63 Patents

#7 in Culver City, CA

#1,345 in California

#5,760 in US

#11,627 in the World

Culver City, CA (US)
Culver City, CA, United States of America

Immunitybio, Inc.

Forward Citations = 77

56 inventors:

goldMedal Patrick Soon-Shiong (25 out of 476 patents)

silverMedal Hans G Klingemann (22 out of 47 patents)

bronzeMedal Laurent H Boissel (18 out of 36 patents)

4.  Hing C Wong (11 out of 111 patents)

5.  Barry J Simon (8 out of 18 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Immunitybio, Inc.. Retrieved from https://idiyas.com/company/immunitybio

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…